- About |
- Contact Us |
- Site Map |
- Privacy Policy |
- Terms Of Use |
- Feedback
23. Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis
CUSTOM BOOKS
Select, organize, download, and save your choice of chapters into a single PDF file for printing and distribution. This is a free service.
My DCPP
Log in to view your saved custom books
CHAPTER INFO
Editors/Authors: Pierre Cattand, Phillippe Desjeux, M. G. Guzmán, Jean Jannin, A. Kroeger, André Médici, Philip Musgrove, Mike B. Nathan, Alexandra Shaw, and C. J. Schofield
Pages: 16
Region
East Asia and Pacific
Europe and Central Asia
Latin America and the Caribbean
Other High Income
South Asia
Sub-Saharan Africa
Disease / Condition
African Trypanosomiasis
Ascariasis
Chagas Disease
Dengue
Diarrheal Disease
Helminth Infections
HIV/AIDS
Infectious Diseases
Intestinal Nematode Infections
Leishmaniasis
Lymphatic Filariasis
Malaria
Onchocerciasis
River Blindness
Schistosomiasis
Trichuriasis
Tropical Diseases
Vaccine-Preventable Diseases
Abstract
Several insect–borne tropical diseases responsible for epidemic outbreaks still lack effective control measures, according to the World Health Organization. Dengue, leishmaniasis, and African trypanosomiasis (sleeping sickness) together result in more than 10 million new infections each year, but treatment is either unavailable or based on antiquated therapies. Vector control is most promising for the tsetse fly, the carrier of sleeping sickness, but requires a sustained organizational response.
All three diseases affect substantial populations. Among them, dengue is the leading cause of pediatric deaths; leishmaniasis is fatal, particularly to males between the ages of 5 and 29; and African trypanosomiasis disproportionately kills adult men?and all take a significant economic toll. The impact of dengue can be measured in terms of medical costs and lost productivity as well as loss of tourist dollars. For leishmaniasis, the cost of both drugs and drug delivery is especially high. The economic impact of sleeping sickness is two–fold: constraining human labor and threatening food supplies when animals succumb to a form of the disease.
Given that there is no specific treatment for dengue and the drugs used to combat leishmaniasis and African trypanosomiasis are quite toxic, the current challenge is to make better use of the tools already available as well as to develop better drugs. An important weapon in the disease–fighting arsenal is a sustainable, long–term surveillance system capable of providing early warning of impending outbreaks. In the case of leishmaniasis and sleeping sickness, early and accurate diagnosis and treatment are essential.
Sections
Click on the links below to read the full text.
